| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1324.23 | 97 |
| GSM780708 | Untreated after 4 days (C2_1) | 1112.57 | 96 |
| GSM780709 | Untreated after 4 days (C3_1) | 1001.25 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 1445.73 | 97 |
| GSM780720 | Untreated after 4 days (C2_2) | 1191.9 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1092.71 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 906.946 | 95 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1271.17 | 97 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1220.86 | 96 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 962.595 | 95 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1381.5 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1332.56 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1184.62 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1050.63 | 96 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1180.57 | 96 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1287.84 | 97 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1095.34 | 96 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1190.09 | 96 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1402.33 | 97 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1086.79 | 96 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1111.42 | 96 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1408.86 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1227.58 | 96 |